EU gene-edited crop rules create opportunity and new constraints
The European Union in June overturned strict limits on cultivating gene-edited crops, a policy change that could reshape the region’s agricultural biotechnology landscape. The new framework divides plants developed with new genomic techniques into NGT-1 and NGT-2 groups: NGT-1 crops with limited alterations are to be regulated like conventionally bred plants, whereas NGT-2 crops remain subject to strict genetically modified organism rules.
The shift follows criticism that Europe has fallen behind other regions in adopting plant biotechnology. It also arrives while climate change and geopolitical instability are increasing pressure on local food security, and while EU restrictions on pesticides and fertilizer use raise demand for crop varieties with broad disease resistance and more efficient nutrient use.
Why the distinction matters for crop development
Gene editing, including CRISPR-based approaches, can make small changes to an organism’s DNA. This differs from some GMO approaches that incorporate DNA from other species, a distinction that has shaped public concern and European regulation. Gene-edited plants can be designed for traits such as drought or heat tolerance and may outperform conventional varieties.
Nico De Storme, a professor of Plant Genetics and Crop Breeding at KU Leuven, argues that the regulatory reversal could be a game-changer for European agriculture. The potential economic stakes are substantial: a 2023 European Commission impact assessment estimated annual losses for EU cereal farmers could reach as much as €2.7 billion, or US$2.3 billion, by the early 2030s without change.
More permissive rules could also support research in the region by reducing the brain drain and loss of intellectual property described over the past decade. However, the practical value of the policy will depend on how the legislation is framed and communicated as implementation proceeds.
Limits on NGT-1 edits remain a central concern
The NGT-1 category is bounded by limits on the number of edits and on the number of DNA base pairs changed in each edit. Those limits are intended to align permitted changes with those that could occur naturally. De Storme argues that the constraints are artificial, because mutations in nature arise randomly without restrictions on their type or number.
Conventional breeding programmes that seek improvements across several traits can involve hundreds of genetic variants. In that context, tight NGT-1 thresholds could make it difficult to combine multiple edited traits in one variety or to improve characteristics controlled by many genes, including yield and resilience to environmental stress.
A product-focused model offers a policy comparison
De Storme recommends that the EU consider greater flexibility as it implements the rules. The United States provides a contrasting model: crops are approved on the basis of the product rather than the breeding method. Regulators examine whether plant characteristics present public-health or ecological risks, rather than focusing on how the plant was created or the precise genetic changes involved.
For agricultural businesses, seed developers and research teams, the immediate implication is to map prospective gene-edited varieties against the NGT-1 and NGT-2 thresholds. Projects that rely on stacking traits or modifying complex genetic characteristics may face a different regulatory route from projects built around a limited edit.